Cargando…

Acenocoumarol Pharmacogenetic Dosing Algorithm versus Usual Care in Patients with Venous Thromboembolism: A Randomised Clinical Trial

Patients with venous thromboembolism (VTE) require immediate treatment with anticoagulants such as acenocoumarol. This multicentre randomised clinical trial evaluated the effectiveness of a dosing pharmacogenetic algorithm versus a standard-of-care dose adjustment at the beginning of acenocoumarol t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Hoi Yan, Borobia, Alberto M., Quintana-Díaz, Manuel, Fabra, Sara, González-Viñolis, Manuel, Fernández-Capitán, Carmen, Rodriguez-Dávila, María A., Lorenzo, Alicia, López-Parra, Ana María, Ruiz-Giménez, Nuria, Abad-Santos, Francisco, Suarez, Carmen, Madridano, Olga, Gómez-Cerezo, Jorge Francisco, Llamas, Pilar, Baeza-Richer, Carlos, Arroyo-Pardo, Eduardo, Carcas, Antonio J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268204/ https://www.ncbi.nlm.nih.gov/pubmed/34209131 http://dx.doi.org/10.3390/jcm10132949

Ejemplares similares

Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial
por: Carcas, Antonio J, et al.
Publicado: (2012)

An Acenocoumarol Dosing Algorithm Using Clinical and Pharmacogenetic Data in Spanish Patients with Thromboembolic Disease
por: Borobia, Alberto M., et al.
Publicado: (2012)

A New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish Population
por: Tong, Hoi Y., et al.
Publicado: (2016)

A Pharmacogenetically Guided Acenocoumarol Dosing Algorithm for Chilean Patients: A Discovery Cohort Study
por: Roco, Angela, et al.
Publicado: (2020)

Acenocoumarol’s pharmacokinetic: linear or not?
por: Kumar, Parveen, et al.
Publicado: (2019)

Therapeutic Dosing of Acenocoumarol: Proposal of a Population Specific Pharmacogenetic Dosing Algorithm and Its Validation in North Indians
por: Rathore, Saurabh Singh, et al.
Publicado: (2012)

Novel Associations of VKORC1 Variants with Higher Acenocoumarol Requirements
por: Anton, Ana Isabel, et al.
Publicado: (2013)

Pharmacogenetics Update on Biologic Therapy in Psoriasis
por: Muñoz-Aceituno, Ester, et al.
Publicado: (2020)

Genetics of Psoriasis and Pharmacogenetics of Biological Drugs
por: Prieto-Pérez, Rocío, et al.
Publicado: (2013)

Acenocoumarol: Lack of efficacy: case report
Publicado: (2022)

Association Studies in Clinical Pharmacogenetics
por: Zubiaur, Pablo, et al.
Publicado: (2022)

Pharmacogenetics of Donepezil and Memantine in Healthy Subjects
por: Ovejero-Benito, María C., et al.
Publicado: (2022)

Clinical Implementation of Pharmacogenetic Testing in a Hospital of the Spanish National Health System: Strategy and Experience Over 3 Years
por: Borobia, Alberto M., et al.
Publicado: (2017)

Predictive engines based on pharmacokinetics modelling for tacrolimus personalized dosage in paediatric renal transplant patients
por: Prado-Velasco, Manuel, et al.
Publicado: (2020)

Toxidermie médicamenteuse secondaire à l'acénocoumarol
por: Khammassi, Naziha, et al.
Publicado: (2015)

Pharmacogenetics of Hypoglycemia Associated with Sulfonylurea Therapy in Usual Clinical Care
por: Mitchell, Sabrina L, et al.
Publicado: (2020)

Advancing pharmacogenetic testing in a tertiary hospital: a retrospective analysis after 10 years of activity
por: Stewart, Stefan, et al.
Publicado: (2023)

Outcomes and Costs of Poisoned Patients Admitted to an Adult Emergency Department of a Spanish Tertiary Hospital: Evaluation through a Toxicovigilance Program
por: Muñoz, Raúl, et al.
Publicado: (2016)

Protective Effect of Pretreatment with Acenocoumarol in Cerulein-Induced Acute Pancreatitis
por: Warzecha, Zygmunt, et al.
Publicado: (2016)

Unusual localization of bleeding under acenocoumarol: Spinal subdural hematoma
por: Aissa, Ismail, et al.
Publicado: (2019)

Acenocoumarol-Induced Diffuse Alveolar Hemorrhage: A Case Report
por: Pawar, Twinkle, et al.
Publicado: (2023)

Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effects
por: Gomez-Sanchez, Clara I., et al.
Publicado: (2017)

Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation
por: Fernández‐Capitán, Carmen, et al.
Publicado: (2020)

The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency
por: Sawicka-Powierza, Jolanta, et al.
Publicado: (2018)

Unintentional ingestion of a high dose of acenocoumarol in a young child
por: Brands, Martijn R, et al.
Publicado: (2021)

Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol
por: Colet, Josep Comín, et al.
Publicado: (2023)

Pharmacogenetics of tacrolimus: ready for clinical translation?
por: Coto, Eliecer, et al.
Publicado: (2011)

Effectiveness and safety of dabigatran versus acenocoumarol in ‘real-world’ patients with atrial fibrillation
por: Korenstra, Jennie, et al.
Publicado: (2016)

Spontaneous Iliopsoas Hematoma in a Patient on Acenocoumarol: Report of a Rare Case
por: El Boté, Hicham, et al.
Publicado: (2023)

Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain
por: Cullell, Natalia, et al.
Publicado: (2020)

Usefulness of Pharmacogenetic Analysis in Psychiatric Clinical Practice: A Case Report
por: Franco-Martin, Manuel A., et al.
Publicado: (2018)

The Role of Clinical Variables and VKORC1 Polymorphism in Efficacy and Stability of Acenocoumarol in Neurological Patients
por: Kumar, Surendra, et al.
Publicado: (2018)

Two Strategies for the Dosage of Acenocoumarol Co-Administered with Rifampicin in Staphylococcal Prosthetic Valve Endocarditis
por: Wełnicki, Marcin, et al.
Publicado: (2021)

Acenocoumarol, an Anticoagulant Drug, Prevents Melanogenesis in B16F10 Melanoma Cells
por: Han, Hyunju, et al.
Publicado: (2023)

Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives
por: Pinto-Merino, Álvaro, et al.
Publicado: (2022)

Therapeutic Effect of Low Doses of Acenocoumarol in the Course of Ischemia/Reperfusion-Induced Acute Pancreatitis in Rats
por: Warzecha, Zygmunt, et al.
Publicado: (2017)

Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis
por: Ceballos, Francisco C., et al.
Publicado: (2023)

Trombosis y COVID-19: revisión de alcance
por: Baselga, María Trinidad, et al.
Publicado: (2022)

Pharmacogenetics of osteoporosis
por: Marini, Francesca, et al.
Publicado: (2010)

Effect of switching from acenocoumarol to phenprocoumon on time in therapeutic range and INR variability: A cohort study
por: van Miert, Jasper H. A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8lrvsckna8anjihavkhc6ba7jq